Press Releases

 
Press Releases
  Date Title and Summary View
May 12, 2016
FREMONT, Calif., May 12, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage specialty pharmaceutical company with proprietary technology for the dermal delivery of drugs, today announced financial results for the first quarter ended March 31, 2016. "Zosano is making progress towards initiating ou...
May 9, 2016
FREMONT, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage specialty pharmaceutical company with proprietary technology for the dermal delivery of drugs, announced today that it named Mr. John P. Walker Chairman of the Board."We are honored to have John joining us at such a transfor...
May 2, 2016
FREMONT, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) today announced that it plans to report financial results for the first quarter of 2016 on Thursday, May 12, 2016. Zosano will host a conference call and webcast to provide an update at 4:30 pm ET (1:30 pm PT) that day. The call will be hos...
Mar 29, 2016
FREMONT, Cali., March 29, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage specialty pharmaceutical company with proprietary microneedle patch technology for the delivery of drugs through the skin, today announced financial results for the fourth quarter and year ended December 31, 2015. The company also pro...
Mar 21, 2016
FREMONT, Calif., March 21, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) today announced that it plans to report financial results for the fourth quarter and full year 2015 on Tuesday, March 29, 2016. Zosano will host a conference call and webcast to provide a corporate update at 4:30 p.m. ET (1:30 p.m. PT) that day. The cal...
Mar 9, 2016
FREMONT, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, today announced that Konstantinos Alataris, Ph.D., President and Chief Executive Officer of Zosano, will provide a company overview at the 28th Annual ROTH Conference on March 14, 2016. The presentat...
Jan 7, 2016
FREMONT, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage pharmaceutical company, today announced the appointment of Konstantinos Alataris, Ph.D. as President and Chief Executive Officer, effective immediately. Dr. Alataris currently serves as the company's President and Chief Operating Offi...
Nov 10, 2015
FREMONT, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) announced today that Vikram Lamba, Chief Executive Officer, will provide a company overview at the Stifel 2015 Healthcare Conference on November 17, 2015. The presentation will take place from 2:15 to 2:55 p.m. ET at the New York Palace Hotel in New Yo...
Nov 9, 2015
FREMONT, Calif., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, today announced financial results for the three months ended September 30, 2015. "We had a very eventful third quarter with updates on all programs. We are particularly pleased with our ...
Nov 3, 2015
FREMONT, Calif., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, announced today that it will release its third-quarter 2015 financial results on Monday, November 9, 2015. In connection with the earnings release, Zosano Pharma will host a conference call an...
Page: FirstPrevious
3
... NextLast
= add release to Briefcase